Tumor cell intracellular replication machinery

The tumor cell intracellular replication machinery is a collective term describing the integrated system of enzymes and proteins, such as DNA polymerases, helicases, and topoisomerases, that execute DNA synthesis and facilitate cell division (Alberts et al., 2002). In oncology, this machinery is not a single molecular target but a functional pathway that is frequently hyperactivated to support the uncontrolled growth characteristic of cancer (Pucci et al., 2000). Therapeutic strategies often involve antimetabolites that deplete nucleotide pools or DNA-damaging agents that stall the replication fork, leading to apoptosis (NCI, 2023). Furthermore, oncolytic virotherapy leverages the high replication rate of this machinery to achieve tumor-selective viral propagation and subsequent oncolysis (Kaufman et al., 2015). Due to the essential nature of DNA replication in healthy regenerative tissues, interventions targeting this machinery often result in significant side effects like myelosuppression and mucositis (Pritchard et al., 2012).

Other names

DNA replication machineryReplisomeCellular proliferative machineryDNA synthesis apparatus

Inhibition of DNA synthesis, induction of DNA damage, or exploitation for selective viral replication.